PLoS ONE (Jan 2022)

Virtual reality immersion compared to monitored anesthesia care for hand surgery: A randomized controlled trial

  • Adeel A. Faruki,
  • Thy B. Nguyen,
  • Doris-Vanessa Gasangwa,
  • Nadav Levy,
  • Sam Proeschel,
  • Jessica Yu,
  • Victoria Ip,
  • Marie McGourty,
  • Galina Korsunsky,
  • Victor Novack,
  • Ariel L. Mueller,
  • Valerie Banner-Goodspeed,
  • Tamara D. Rozental,
  • Brian P. O’Gara

Journal volume & issue
Vol. 17, no. 9

Abstract

Read online

Introduction Common anesthesia practice for hand surgery combines a preoperative regional anesthetic and intraoperative monitored anesthesia care (MAC). Despite adequate regional anesthesia, patients may receive doses of intraoperative sedatives which can result in oversedation and potentially avoidable complications. VR could prove to be a valuable tool for patients and providers by distracting the mind from processing noxious stimuli resulting in minimized sedative use and reduced risk of oversedation without negatively impacting patient satisfaction. Our hypothesis was that intraoperative VR use reduces sedative dosing during elective hand surgery without detracting from patient satisfaction as compared to a usual care control. Methods Forty adults undergoing hand surgery were randomized to receive either intraoperative VR in addition to MAC, or usual MAC. Patients in both groups received preoperative regional anesthesia at provider discretion. Intraoperatively, the VR group viewed programming of their choice via a head-mounted display. The primary outcome was intraoperative propofol dose per hour (mg · hr-1). Secondary outcomes included patient reported pain and anxiety, overall satisfaction, functional outcome, and post anesthesia care unit (PACU) length of stay (LOS). Results Of the 40 enrolled patients, 34 completed the perioperative portion of the trial. VR group patients received significantly less propofol per hour than the control group (Mean (±SD): 125.3 (±296.0) vs 750.6 (±334.6) mg · hr-1, pConclusion VR immersion during hand surgery led to significant reductions in intraoperative propofol dose and PACU LOS without negatively impacting key patient reported outcomes.